196 related articles for article (PubMed ID: 31421864)
21. Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
Eshaghi A; Bodini B; Ridgway GR; García-Lorenzo D; Tozer DJ; Sahraian MA; Thompson AJ; Ciccarelli O
Neuroimage; 2014 Feb; 86():257-64. PubMed ID: 24099844
[TBL] [Abstract][Full Text] [Related]
22. Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study.
Bergsland N; Horakova D; Dwyer MG; Uher T; Vaneckova M; Tyblova M; Seidl Z; Krasensky J; Havrdova E; Zivadinov R
Neuroimage Clin; 2018; 17():444-451. PubMed ID: 29159057
[TBL] [Abstract][Full Text] [Related]
23. Disruption of the Atrophy-based Functional Network in Multiple Sclerosis Is Associated with Clinical Disability: Validation of a Meta-Analytic Model in Resting-State Functional MRI.
Chiang FL; Feng M; Romero RS; Price L; Franklin CG; Deng S; Gray JP; Yu FF; Tantiwongkosi B; Huang SY; Fox PT
Radiology; 2021 Apr; 299(1):159-166. PubMed ID: 33529135
[TBL] [Abstract][Full Text] [Related]
24. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
[TBL] [Abstract][Full Text] [Related]
25. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
27. Progression of regional grey matter atrophy in multiple sclerosis.
Eshaghi A; Marinescu RV; Young AL; Firth NC; Prados F; Jorge Cardoso M; Tur C; De Angelis F; Cawley N; Brownlee WJ; De Stefano N; Laura Stromillo M; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Geurts JJG; Vrenken H; Wottschel V; Leurs CE; Uitdehaag B; Pirpamer L; Enzinger C; Ourselin S; Gandini Wheeler-Kingshott CA; Chard D; Thompson AJ; Barkhof F; Alexander DC; Ciccarelli O
Brain; 2018 Jun; 141(6):1665-1677. PubMed ID: 29741648
[TBL] [Abstract][Full Text] [Related]
28. Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability.
Lansley J; Mataix-Cols D; Grau M; Radua J; Sastre-Garriga J
Neurosci Biobehav Rev; 2013 Jun; 37(5):819-30. PubMed ID: 23518268
[TBL] [Abstract][Full Text] [Related]
29. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin.
Pontillo G; Petracca M; Monti S; Quarantelli M; Lanzillo R; Costabile T; Carotenuto A; Tortora F; Elefante A; Morra VB; Brunetti A; Palma G; Cocozza S
Eur Radiol; 2023 Mar; 33(3):2185-2194. PubMed ID: 36241917
[TBL] [Abstract][Full Text] [Related]
31. Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.
Seraji-Bozorgzad N; Khan O; Cree BAC; Bao F; Caon C; Zak I; Razmjou S; Tselis A; Millis S; Bernitsas E
J Neuroimaging; 2017 Sep; 27(5):476-480. PubMed ID: 28371088
[TBL] [Abstract][Full Text] [Related]
32. Voxelwise Meta-Analysis of Gray Matter Abnormalities in Mild Cognitive Impairment and Subjective Cognitive Decline Using Activation Likelihood Estimation.
Chen S; Xu W; Xue C; Hu G; Ma W; Qi W; Dong L; Lin X; Chen J
J Alzheimers Dis; 2020; 77(4):1495-1512. PubMed ID: 32925061
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of single-subject grey matter networks in early multiple sclerosis.
Fleischer V; Gonzalez-Escamilla G; Pareto D; Rovira A; Sastre-Garriga J; Sowa P; Høgestøl EA; Harbo HF; Bellenberg B; Lukas C; Ruggieri S; Gasperini C; Uher T; Vaneckova M; Bittner S; Othman AE; Collorone S; Toosy AT; Meuth SG; Zipp F; Barkhof F; Ciccarelli O; Groppa S
Brain; 2024 Jan; 147(1):135-146. PubMed ID: 37642541
[TBL] [Abstract][Full Text] [Related]
34. Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis.
Zhang M; Gao X; Yang Z; Wen M; Huang H; Zheng R; Wang W; Wei Y; Cheng J; Han S; Zhang Y
Psychopharmacology (Berl); 2021 Sep; 238(9):2365-2379. PubMed ID: 34313804
[TBL] [Abstract][Full Text] [Related]
35. Shared gray matter alterations in individuals with diverse behavioral addictions: A voxel-wise meta-analysis.
Qin K; Zhang F; Chen T; Li L; Li W; Suo X; Lei D; Kemp GJ; Gong Q
J Behav Addict; 2020 Apr; 9(1):44-57. PubMed ID: 32359230
[TBL] [Abstract][Full Text] [Related]
36. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
[TBL] [Abstract][Full Text] [Related]
37. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
Xiang B; Wen J; Cross AH; Yablonskiy DA
J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
[TBL] [Abstract][Full Text] [Related]
38. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
39. Lifespan neurodegeneration of the human brain in multiple sclerosis.
Coupé P; Planche V; Mansencal B; Kamroui RA; Koubiyr I; Manjòn JV; Tourdias T
Hum Brain Mapp; 2023 Dec; 44(17):5602-5611. PubMed ID: 37615064
[TBL] [Abstract][Full Text] [Related]
40. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
